ロード中...
Rationale for targeted therapies and potential role of pazopanib in advanced renal cell carcinoma
Advanced renal cell carcinoma (RCC) remains a challenging, major health problem. Recent advances in understanding the fundamental biology underlying one form of RCC, ie, clear cell (or conventional) RCC, have opened the door to a series of targeted agents, such as the tyrosine kinase inhibitors (TKI...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2921256/ https://ncbi.nlm.nih.gov/pubmed/20714356 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|